Chapter 1. ORAL BIOLOGICS MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. ORAL BIOLOGICS MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. ORAL BIOLOGICS MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. ORAL BIOLOGICS MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. ORAL BIOLOGICS MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. ORAL BIOLOGICS MARKET – by Drug Class

6.1. Glucagon-like peptide 1 (GLP-1) Receptor Agonist

6.2. Guanylate Cyclase-C Agonist

6.3. Hormone

6.4. Recombinant Enzyme

6.5. Somatostatin Analougue

6.6. Others 

Chapter 7. ORAL BIOLOGICS MARKET – By Disease Indication

7.1. Acromegaly

7.2. Chronic Idiopathic Constipation (CIC)

7.3. Diabetes

7.4. Hyperoxaluria

7.5. Hypoparathyroidism

7.6. Inflammatory Bowel Disease (IBD)

7.7. Irritable Bowel Syndrome (IBS)

7.8. Rheumatoid Arthritis

Chapter 8. ORAL BIOLOGICS MARKET – By Distribution Channel

8.1. Hospital pharmacies

8.2. Retail pharmacies

8.3. Online pharmacies

Chapter 9. ORAL BIOLOGICS MARKET – By Region

9.1. North America

9.2. Europe

9.3.The Asia Pacific

9.4.Latin America

9.5. Middle-East and Africa

Chapter 10. ORAL BIOLOGICS MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10